Polio virus neutralisation assay

DM David A. Muller
FP Frances E. Pearson
GF Germain J.P. Fernando
CA Christiana Agyei-Yeboah
NO Nick S. Owens
SC Simon R. Corrie
MC Michael L. Crichton
JW Jonathan C.J. Wei
WW William C. Weldon
MO M. Steven Oberste
PY Paul R. Young
MK Mark A. F. Kendall
request Request a Protocol
ask Ask a question
Favorite

To evaluate the immune response elicited by vaccination, poliovirus neutralisation assays were performed at the CDC as previously published by WHO41,42,43. Briefly, all samples were diluted 1 in 4, mixed with 80–100 CCID50 of each poliovirus (Sabin 1, 2 or 3) and incubated for 3 hours at 35 °C, then added to HEp-2c cells (7,500 cells per well) in 96-well plates. Plates were incubated at 35 °C, 5% CO2 for 5 days at which point cells were stained with crystal violet and CPE measured by optical density at 570 nm. Neutralisation titres were reported as reciprocal 50% endpoint titres determined by the Spearman-Karber method44. Positive samples are defined as having ≥ 3.0 log2 titre with an assay background of 2.5 log2 titre.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A